NEW YORK (GenomeWeb News) – Danaher will spend $1.1 billion to acquire the Analytical Technologies division of MDS, including the mass spectrometry joint venture with Life Technologies.

Under the deal, MDS will receive $650 million in cash, while Life Technologies will get $450 million for its stake in the JV.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.